YH-53 is 3CL Protease Inhibitor with an Electrophilic Arylketone Moiety as Anti-SARS-CoV‑2 Agent. YH-53 can strongly block the SARSCoV-2 replication. X-ray structural analysis revealed that YH-53 establishes multiple hydrogen bond interactions with backbone amino acids and a covalent bond with the active site of 3CLpro. Further results from computational and experimental studies, including an in vitro absorption, distribution, metabolism, and excretion profile, in vivo pharmacokinetics, and metabolic analysis of YH-53 suggest that it has a high potential as a lead candidate to compete with COVID-19.
MedKoo Cat#: 465223
Name: YH-53
CAS#: 1471484-62-4
Chemical Formula: C30H33N5O5S
Exact Mass: 575.2202
Molecular Weight: 575.68
Elemental Analysis: C, 62.59; H, 5.78; N, 12.17; O, 13.90; S, 5.57
The following data is based on the product molecular weight 575.68 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |